Literature DB >> 8815961

Drug tasting may confound human drug discrimination studies.

M E Abreu1, R R Griffiths.   

Abstract

Unpublished observations suggested that some subjects in human drug discrimination studies acquired a drug versus placebo discrimination by tasting the capsule contents. To evaluate the prevalence of this behavior and to develop approaches to circumvent this problem, 30 normal human subjects participated in a drug discrimination study in which the study capsules (i.e., lactose and lactose + quinine) could be discriminated by tasting the capsule contents but were otherwise pharmacologically indistinguishable. Twenty percent of the subjects significantly discriminated between the capsules; this discrimination was disrupted by employing thorough mouth checks following capsule administration. Based on these findings, we recommend that human drug discrimination studies incorporate procedures that minimize the possibility of drug tasting by requiring consumption of sufficient fluid in combination with rigorous mouth checks to ensure capsule swallowing.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8815961     DOI: 10.1007/bf02247336

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  6 in total

1.  Dose-related caffeine discrimination in normal volunteers: individual differences in subjective effects and self-reported cues.

Authors:  S.M. Evans; R.R. Griffiths
Journal:  Behav Pharmacol       Date:  1991-11       Impact factor: 2.293

2.  Low-dose caffeine discrimination and self-reported mood effects in normal volunteers.

Authors:  K Silverman; R R Griffiths
Journal:  J Exp Anal Behav       Date:  1992-01       Impact factor: 2.468

3.  Pharmacological specificity of the caffeine discriminative stimulus in humans: effects of theophylline, methylphenidate and buspirone.

Authors:  A.H. Oliveto; W.K. Bickel; J.R. Hughes; S.Y. Terry; S.T. Higgins; G.J. Badger
Journal:  Behav Pharmacol       Date:  1993-06       Impact factor: 2.293

4.  Subjective and discriminative effects of drugs.

Authors:  K.L. Preston; G.E. Bigelow
Journal:  Behav Pharmacol       Date:  1991-11       Impact factor: 2.293

Review 5.  Drug discrimination by humans compared to nonhumans: current status and future directions.

Authors:  J B Kamien; W K Bickel; J R Hughes; S T Higgins; B J Smith
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  Discriminative stimulus and subjective effects of theobromine and caffeine in humans.

Authors:  G K Mumford; S M Evans; B J Kaminski; K L Preston; C A Sannerud; K Silverman; R R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  1994-06       Impact factor: 4.530

  6 in total
  15 in total

1.  Acute effects of alprazolam on risky decision making in humans.

Authors:  Scott D Lane; Oleg V Tcheremissine; Lori M Lieving; Sylvain Nouvion; Don R Cherek
Journal:  Psychopharmacology (Berl)       Date:  2005-04-14       Impact factor: 4.530

2.  Relationship between oral D-amphetamine self-administration and ratings of subjective effects: do subjective-effects ratings correspond with a progressive-ratio measure of drug-taking behavior?

Authors:  B Levi Bolin; Anna R Reynolds; William W Stoops; Craig R Rush
Journal:  Behav Pharmacol       Date:  2013-09       Impact factor: 2.293

3.  GABAergic modulation of human social interaction in a prisoner's dilemma model by acute administration of alprazolam.

Authors:  Scott D Lane; Joshua L Gowin
Journal:  Behav Pharmacol       Date:  2009-10       Impact factor: 2.293

4.  Amphetamine self-administration in light and moderate drinkers.

Authors:  Matthew D Stanley; Mégan M Poole; William W Stoops; Craig R Rush
Journal:  Alcohol Clin Exp Res       Date:  2010-12-16       Impact factor: 3.455

5.  Methylphenidate does not influence smoking-reinforced responding or attentional performance in adult smokers with and without attention deficit hyperactivity disorder (ADHD).

Authors:  Scott H Kollins; Erin Schoenfelder; Joseph S English; F Joseph McClernon; Rachel E Dew; Scott D Lane
Journal:  Exp Clin Psychopharmacol       Date:  2013-10       Impact factor: 3.157

6.  Acute d-amphetamine pretreatment does not alter stimulant self-administration in humans.

Authors:  William W Stoops; Andrea R Vansickel; Joshua A Lile; Craig R Rush
Journal:  Pharmacol Biochem Behav       Date:  2007-04-05       Impact factor: 3.533

7.  Baclofen does not alter the reinforcing, subject-rated or cardiovascular effects of intranasal cocaine in humans.

Authors:  Joshua A Lile; William W Stoops; Timothy S Allen; Paul E A Glaser; Lon R Hays; Craig R Rush
Journal:  Psychopharmacology (Berl)       Date:  2003-09-19       Impact factor: 4.530

8.  An exploratory study of the combined effects of orally administered methylphenidate and delta-9-tetrahydrocannabinol (THC) on cardiovascular function, subjective effects, and performance in healthy adults.

Authors:  Scott H Kollins; Erin N Schoenfelder; Joseph S English; Alex Holdaway; Elizabeth Van Voorhees; Benjamin R O'Brien; Rachel Dew; Allan K Chrisman
Journal:  J Subst Abuse Treat       Date:  2014-08-07

9.  Reinforcing and subjective effects of methylphenidate in adults with and without attention deficit hyperactivity disorder (ADHD).

Authors:  Scott H Kollins; Joseph English; Rachel Robinson; Matt Hallyburton; Allan K Chrisman
Journal:  Psychopharmacology (Berl)       Date:  2008-12-23       Impact factor: 4.530

10.  Discriminative stimulus and subject-rated effects of methamphetamine, d-amphetamine, methylphenidate, and triazolam in methamphetamine-trained humans.

Authors:  Rajkumar J Sevak; William W Stoops; Lon R Hays; Craig R Rush
Journal:  J Pharmacol Exp Ther       Date:  2008-12-22       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.